View Community-reported Fabrazyme side effects
Add Your Side Effect to the Community Database
Help Community - Describe Your Fabrazyme Side Effect
Have You dealt with a Fabrazyme side effect? Share your experience
Fabrazyme Side Effects summary
Total Fabrazyme reports: 435.Fabrazyme FDA safety alerts: No.
Reported deaths: 90 Reported hospitalizations: 289.
Take Fabrazyme Side Effects Survey, Discuss Fabrazyme with others
Fabrazyme Side Effects: infusion related reaction, condition aggravated, renal transplant, chills, renal failure chronic, pain in extremity, myocardial infarction, dyspnoea, dyspnoea exertional, nausea, oedema peripheral,
More About Fabrazyme.
If you have questions about Fabrazyme, you can ask a Health Expert or Ask Patient Community about Fabrazyme.
Fabrazyme Side Effects reported to FDA
Showing 1-40 of 435 Next >
Fabrazyme Side Effects Report #5692070-8Physician from VENEZUELA reported FABRAZYME problem on Mar 25, 2008. Male patient, 35 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: convulsion. FABRAZYME dosage: unknown. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5614729-0
FABRAZYME problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 24, 2008. Male patient, 64 years of age, weighting 110.0 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: prostate cancer. FABRAZYME dosage: 1 MG/KG, Q2W. Patient recovered.
Fabrazyme Side Effects Report #5623831-9
Health Professional from UNITED STATES reported FABRAZYME problem on Jan 30, 2008. Female patient, 54 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: coronary artery occlusion. FABRAZYME dosage: 1 MG/KG,Q2W; INTRAVENOUS. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5625165-5
FABRAZYME problem was reported by a Physician from JAPAN on Jan 30, 2008. Male patient, 17 years of age, weighting 121.3 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: meningitis viral, nasopharyngitis. FABRAZYME dosage: 55 MG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5625166-7
Physician from GERMANY reported FABRAZYME problem on Jan 25, 2008. Female patient, 43 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: central nervous system lesion, cerebral infarction. FABRAZYME dosage: unknown. During the same period patient was treated with LEVOTHYROXINE. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5625171-0
FABRAZYME problem was reported by a Physician from SWEDEN on Jan 25, 2008. Male patient, 63 years of age, weighting 194.0 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: cardiac failure. FABRAZYME dosage: 70 MG, Q2W, INTRAVENOUS. During the same period patient was treated with RAMIPRIL, SELOKEN ZOC, SIMVASTATIN, WARFARIN. Patient died on 11/06/2007.
Fabrazyme Side Effects Report #5625444-1
Health Professional from UNITED KINGDOM reported FABRAZYME problem on Jan 28, 2008. Male patient, 39 years of age, weighting 176.4 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: acute prerenal failure, clostridium difficile colitis, hypovolaemia, poor venous access. FABRAZYME dosage: 80 MG, Q2W, INTRAVENOUS; 70 MG, Q2W, INTRAVENOUS; 1 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5629776-2
FABRAZYME problem was reported by a Physician from DENMARK on Jan 31, 2008. Female patient, 58 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: dysphagia, hypersensitivity, respiratory disorder. FABRAZYME dosage: 1 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, RISEDRONATE. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5630026-1
Physician from DENMARK reported FABRAZYME problem on Jan 31, 2008. Female patient, 35 years of age, weighting 123.5 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: hypersensitivity, obstructive airways disorder, pruritus. FABRAZYME dosage: 1 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with GABAPENTIN, ACETYLSALICYLIC ACID SRT. Patient recovered.

Fabrazyme Side Effects Report #5631577-6
FABRAZYME problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 01, 2008. Female patient, 50 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: insomnia, suicide attempt. FABRAZYME dosage: 80 MG, Q2W, INTRAVENOUS. During the same period patient was treated with ZOLOFT, PROZAC. Patient recovered.
Fabrazyme Side Effects Report #5631579-X
Consumer or non-health professional from UNITED STATES reported FABRAZYME problem on Feb 01, 2008. Male patient, 51 years of age, weighting 187.4 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: dizziness, dyspnoea exertional, echocardiogram abnormal, ejection fraction decreased, heart rate irregular, hypoaesthesia, hypoaesthesia oral. FABRAZYME dosage: 85 MG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5631598-3
FABRAZYME problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 05, 2008. Male patient, 55 years of age, weighting 213.8 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: ill-defined disorder. FABRAZYME dosage: unknown. Patient was hospitalized. Patient died on 02/02/2008.
Fabrazyme Side Effects Report #5635731-9
Physician from MEXICO reported FABRAZYME problem on Feb 07, 2008. Male patient, 45 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: anaemia, lymphoma, pyrexia, weight decreased. FABRAZYME dosage: 1 MG/KG, Q2W, INTRAVENOUS. Patient recovered.
Fabrazyme Side Effects Report #5635829-5
FABRAZYME problem was reported by a Physician from JAPAN on Feb 07, 2008. Male patient, 17 years of age, weighting 121.3 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: meningitis viral. FABRAZYME dosage: 55 MG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5637739-6
Consumer or non-health professional from UNITED STATES reported FABRAZYME problem on Feb 07, 2008. Female patient, 65 years of age, weighting 119.0 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: back pain, hypercalcaemia, metabolic acidosis, nephrolithiasis, troponin increased. FABRAZYME dosage: 1 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with BENADRYL, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5637740-2
FABRAZYME problem was reported by a Pharmacist from UNITED STATES on Feb 07, 2008. Male patient, 48 years of age, weighting 159.8 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: device related infection, osteomyelitis. FABRAZYME dosage: 70 MG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5637741-4
Health Professional from UNITED STATES reported FABRAZYME problem on Feb 07, 2008. Male patient, 53 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: thyroid disorder. FABRAZYME dosage: 1 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5637743-8
FABRAZYME problem was reported by a Physician from UNITED STATES on Feb 06, 2008. Female patient, 55 years of age, weighting 231.5 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: abdominal abscess, abdominal pain upper, asthenia, cholecystitis, constipation, decubitus ulcer, enterocutaneous fistula, pancreatitis, sepsis. FABRAZYME dosage: 105 MG, Q2WK. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5639760-0
Physician from UNITED STATES reported FABRAZYME problem on Feb 13, 2008. Female patient, weighting 13.89 lb, was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: abscess neck, branchial cyst, cellulitis, dermatitis diaper, staphylococcal infection. FABRAZYME dosage: unknown. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5640794-0
FABRAZYME problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 20, 2008. Female patient, 55 years of age, weighting 231.5 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation. FABRAZYME dosage: 105 MG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5642161-2
Physician from ITALY reported FABRAZYME problem on Feb 08, 2008. Male patient was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: aortic aneurysm, dialysis, ill-defined disorder, post procedural complication, renal failure acute. FABRAZYME dosage: 500 MG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient died on 01/01/2008.
Fabrazyme Side Effects Report #5642164-8
FABRAZYME problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 11, 2008. Female patient was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, choking, epistaxis, infusion related reaction, syncope. FABRAZYME dosage: 35 MG, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5642165-X
Consumer or non-health professional from UNITED KINGDOM reported FABRAZYME problem on Feb 11, 2008. Female patient was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, choking, epistaxis, infusion related reaction, syncope. FABRAZYME dosage: 35 MG, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5642476-8
FABRAZYME problem was reported by a Physician from GERMANY on Feb 12, 2008. Male patient, 43 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: chills, hot flush, infusion related reaction, musculoskeletal pain, oxygen saturation decreased, vomiting projectile. FABRAZYME dosage: 70 MG, INTRAVENOUS. During the same period patient was treated with CELLCEPT, PROGRAF, BISOPROLOL, DECORTIN, CANDESARTAN CILEXETIL, TRIMIPRAMINE MALEATE, LASIX, TAXILAN. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5646796-2
Physician from JAPAN reported FABRAZYME problem on Feb 18, 2008. Male patient, 59 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: c-reactive protein increased, pyrexia. FABRAZYME dosage: 55 MG, Q2W, INTRAVENOUS. During the same period patient was treated with REPLAGAL. Patient died on 01/27/2008.
Fabrazyme Side Effects Report #5646798-6
FABRAZYME problem was reported by a Physician from GERMANY on Feb 14, 2008. Female patient, 43 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: central nervous system lesion, cerebral infarction, cerebrovascular accident, sudden hearing loss, tinnitus. FABRAZYME dosage: 70 MG, Q2W, INTRAVENOUS. During the same period patient was treated with LEVOTHYROXINE. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5648172-5
Consumer or non-health professional from UNITED STATES reported FABRAZYME problem on Feb 22, 2008. Female patient, 78 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage, clostridial infection, fall, head injury. FABRAZYME dosage: unknown. Patient was hospitalized. Patient died on 02/05/2008.
Fabrazyme Side Effects Report #5649168-X
FABRAZYME problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 20, 2008. Male patient, 30 years of age, weighting 176.4 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: appendicectomy. FABRAZYME dosage: 80 MG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5649176-9
Physician from UNITED STATES reported FABRAZYME problem on Feb 22, 2008. Female patient, 55 years of age, weighting 231.5 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation. FABRAZYME dosage: 105 MG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5584705-5
FABRAZYME problem was reported by a Health Professional from UNITED KINGDOM on Dec 19, 2007. Male patient, 21 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, infusion related reaction. FABRAZYME dosage: unknown. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5585986-4
Consumer or non-health professional from UNITED STATES reported FABRAZYME problem on Dec 26, 2007. Female patient was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: arterial disorder, iliac artery occlusion, myocardial infarction, thrombosis in device, vascular occlusion. FABRAZYME dosage: 70 MG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5590351-X
FABRAZYME problem was reported by a Physician from UNITED STATES on Jan 04, 2008. Male patient, 34 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: depression, overdose. FABRAZYME dosage: 70 MG, QW, INTRAVENOUS; 70 MG, Q2W, INTRAVENOUS. During the same period patient was treated with BENADRYL, ZOFRAN, DEMEROL. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5590594-5
Physician from UNITED STATES reported FABRAZYME problem on Jan 07, 2008. Male patient, 26 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: spinal disorder, staphylococcal osteomyelitis, treatment noncompliance. FABRAZYME dosage: 1 MG/KG, Q2W, INTRAVENOUS; 1MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5591385-1
FABRAZYME problem was reported by a Physician from UNITED STATES on Dec 28, 2007. Male patient, 52 years of age, weighting 158.3 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: ageusia, areflexia, asthenia, cerebral disorder, cranial operation, ear infection, guillain-barre syndrome, hearing impaired, hypoaesthesia. FABRAZYME dosage: 75 MG, Q2W, INTRAVENOUS. Patient was hospitalized and became disabled. Patient recovered.
Fabrazyme Side Effects Report #5603325-7
Pharmacist from GERMANY reported FABRAZYME problem on Jan 09, 2008. Male patient was diagnosed with fabry's disease and was treated with FABRAZYME. FABRAZYME dosage: unknown. Patient died on 01/01/2007.
Fabrazyme Side Effects Report #5604968-7
FABRAZYME problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 11, 2008. Male patient, 46 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: meningitis bacterial. FABRAZYME dosage: unknown. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5605453-9
Physician from POLAND reported FABRAZYME problem on Jan 09, 2008. Male patient was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: amputation, bone density decreased, cardiac valve disease, chills, dyspnoea, extremity necrosis, heart valve incompetence, impaired healing, inflammation. FABRAZYME dosage: 1 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, STEROIDS, METHYLPREDNISOLONE, ACETAMINOPHEN, ACE INHIBITOR NOS, BETA BLOCKING AGENTS, STATIN. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5606758-8
FABRAZYME problem was reported by a Physician from UNITED STATES on Jan 11, 2008. Male patient, 52 years of age, weighting 158.3 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, back pain, blood creatinine increased, blood pressure decreased, bradycardia, dural tear, ear infection, eosinophilia, guillain-barre syndrome. FABRAZYME dosage: 75 MG,Q2W, INTRAVENOUS. Patient was hospitalized and became disabled. Patient recovered.
Fabrazyme Side Effects Report #5610434-5
Health Professional from UNITED STATES reported FABRAZYME problem on Jan 16, 2008. Female patient, 54 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: cardiac disorder. FABRAZYME dosage: 1 MG/KG, Q2W; INTRAVENOUS. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5610435-7
FABRAZYME problem was reported by a Physician from UNITED STATES on Jan 16, 2008. Male patient, 47 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: bladder disorder, bladder perforation, chest pain, dyspnoea, fatigue, iatrogenic injury, post procedural complication, prostatic disorder. FABRAZYME dosage: 1 MG/KG, Q2W; INTRAVENOUS, 1 MG/KG, INTRAVENOUG. Patient was hospitalized. Patient recovered.
Showing 1-40 of 435 Next >
Fabrazyme Side Effects


